TSVETKOVA, VASSILENA
 Distribuzione geografica
Continente #
NA - Nord America 562
AS - Asia 104
EU - Europa 74
AF - Africa 5
SA - Sud America 5
Totale 750
Nazione #
US - Stati Uniti d'America 561
SG - Singapore 48
CN - Cina 43
IT - Italia 23
FI - Finlandia 10
SE - Svezia 9
DE - Germania 7
CI - Costa d'Avorio 5
GB - Regno Unito 5
IN - India 5
BR - Brasile 4
FR - Francia 4
IE - Irlanda 3
NL - Olanda 3
RU - Federazione Russa 3
AT - Austria 2
CZ - Repubblica Ceca 2
HK - Hong Kong 2
AL - Albania 1
AR - Argentina 1
BE - Belgio 1
CH - Svizzera 1
ID - Indonesia 1
IQ - Iraq 1
JP - Giappone 1
KR - Corea 1
KZ - Kazakistan 1
MX - Messico 1
MY - Malesia 1
Totale 750
Città #
Chandler 97
Fairfield 88
Woodbridge 50
Ashburn 48
Cambridge 41
Wilmington 32
Singapore 29
Ann Arbor 27
Houston 27
Seattle 27
Boardman 11
Beijing 10
Helsinki 10
Medford 8
Princeton 8
Roxbury 8
San Diego 7
Codogno 6
Des Moines 6
Abidjan 5
Dallas 5
Santa Clara 5
Dublin 3
Guangzhou 3
London 3
Padova 3
Pune 3
Amsterdam 2
Bergamo 2
Caserta 2
Falkenstein 2
Jinan 2
Milan 2
Nanjing 2
New York 2
Olomouc 2
Rome 2
Tianjin 2
Washington 2
Zanica 2
Almaty 1
Brussels 1
Changsha 1
Chiswick 1
Dongguan 1
Guarulhos 1
Gustavo Adolfo Madero 1
Hangzhou 1
Joinville 1
Kuala Lumpur 1
Laferrere 1
Los Angeles 1
Nanchang 1
Nanning 1
Norwalk 1
Nuremberg 1
Pirapora 1
Prescot 1
Redwood City 1
Rockville 1
Santos 1
Seoul 1
Shanghai 1
Shenyang 1
Surabaya 1
Suzhou 1
Tirana 1
Tokyo 1
Zhengzhou 1
Zurich 1
Totale 626
Nome #
Exceptional and Durable Responses to TDM-1 After Trastuzumab Failure for Breast Cancer Skin Metastases: Potential Implications of an Immunological Sanctuary 143
Androgen receptor expression and association with distant disease-free survival in triple negative breast cancer: Analysis of 263 patients treated with standard therapy for stage I-III disease 137
Immune characterization of breast cancer metastases: Prognostic implications 131
Validation of Residual Proliferative Cancer Burden as a Predictor of Long-Term Outcome Following Neoadjuvant Chemotherapy in Patients with Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer 83
Integration of tumour infiltrating lymphocytes, programmed cell-death ligand-1, CD8 and FOXP3 in prognostic models for triple-negative breast cancer: Analysis of 244 stage I–III patients treated with standard therapy 79
Erbb2 mrna expression and response to ado-trastuzumab emtansine (T-dm1) in her2-positive breast cancer 67
Prognostic factors in phyllodes tumours of the breast: retrospective study on 166 consecutive cases 66
Impact of estrogen receptor levels on outcome in non-metastatic triple negative breast cancer patients treated with neoadjuvant/adjuvant chemotherapy 60
Totale 766
Categoria #
all - tutte 3.527
article - articoli 3.527
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.054


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202040 0 0 0 0 0 0 0 0 12 16 7 5
2020/2021135 2 4 7 7 0 27 7 8 31 22 10 10
2021/2022121 1 0 16 10 16 14 1 11 9 7 6 30
2022/2023137 22 22 11 24 14 22 0 4 11 0 6 1
2023/202491 10 7 12 5 13 11 9 6 0 6 5 7
2024/2025119 0 15 11 14 22 4 13 16 24 0 0 0
Totale 766